Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Satisfaction With Rimegepant and Triptans Utilizing Migraine Buddy Retrospective Data

NCT06532357 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06532357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06532357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Satisfaction With Rimegepant and Triptans Utilizing Migraine Buddy Retrospective Data
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
June 9, 2024
Completion date
June 10, 2024
Enrollment
1,536 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine